Strategic position Phenomenex sits under Danaher, leveraging a broad ecosystem and the Danaher Business System to drive faster, more reliable science. This presents opportunities to position integrated analytical solutions and services that align with Danaher’s performance improvement and operational excellence initiatives.

Portfolio expansion Recent launches such as Luna Omega HILIC LC columns, Endrix Long Life LC column, Clarity OTX Pro, and micro/nano traps signal a continuous product refresh. Target prospects with evolving separation needs and emphasize compatibility with existing platforms to unlock upsell or cross-sell of new consumables and columns.

Technical need The focus on advanced purification, PFAS design, AAV study tooling, and high-polarity separations indicates demand for robust, high-performance SPE cartridges, LC columns, and workflows. Sales can target labs expanding analytical capabilities, regulatory testing, and environmental/biomedical research with optimized separation solutions.

Global reach With 60,000 Danaher colleagues and a worldwide footprint, Phenomenex has broad access to multinational customers across pharma, government, and academia. Opportunities exist to partner on large-scale procurement, standardized testing programs, and cross-border trials requiring consistent analytical supplies.

Financial readiness Revenue is in the mid-range of enterprise suppliers ($250M-$500M), suggesting room for growth via expanded product adoption, service contracts, and bundled offerings. Target growth accounts with high annual spend in chromatography consumables and instrument integration.